Integrated Chinese and Western treatment for ankylosing spondylitis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter, ambidirectional observational cohort combining three years of retrospective data with up to two years of prospective follow-up to study long-term outcomes. Participants are adults meeting the 1984 modified New York criteria or the 2009 ASAS axial spondyloarthritis criteria and are treated with integrated traditional Chinese and Western approaches in routine care. Radiographic progression will be quantified using the SPARCC scoring system across participating hospitals in China. No experimental drug is assigned by the protocol; the study analyzes outcomes under real-world integrated care while excluding patients with other autoimmune diseases, pregnancy, severe organ failure, or malignancy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* fulfill the 1984 modified New York criteria for ankylosing spondylitis or the 2009 Assessment of SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis
* age between 18 and 75 years
* sign informed consent.

Exclusion Criteria:

* diagnosis of other autoimmune diseases besides the disease under investigation (e.g., rheumatoid arthritis, Sjögren's syndrome, erythema nodosum, myositis, etc.)
* pregnancy or lactation
* comorbid severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or malignancy
* spondyloarthritis related to enteropathic arthritis, psoriatic arthritis, or reactive arthritis
* unable to provide data due to mental, language, or similar factors.

Where it's running

• China-Japan Friendship Hospital
  Beijing, Beijing, China, China Recruiting

Study contacts

• Study coordinator: Yuanyuan Zou, Doctor
• Email: zyysdmn1234@163.com
• Phone: +86 18080935783

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MST-931 in healthy adults

  This early-phase study tests a single subcutaneous dose of MST-931 to see if it is safe and how it behaves in the body in healthy adults.

  Recruiting Phase 1 Mabsoft Therapeutics (Shanghai) Co., Ltd. · Herston, Queensland · NCT07903493

• ESPB for persistent back pain in ankylosing spondylitis

  This trial tests whether an erector spinae plane block can help reduce persistent back pain in adults with ankylosing spondylitis who still have pain despite controlled disease activity.

  Recruiting Marmara University · Istanbul, Pendik · NCT07633730

• Effect of smartphone use on neck posture and function in RA/AS patients and healthy controls

  This study tests how smartphone use relates to neck posture, tongue pressure, balance, and neck-related disability in people with rheumatoid arthritis or ankylosing spondylitis compared with healthy individuals.

  Recruiting Necmettin Erbakan University · Konya, Meram · NCT07627542

• Combining Traditional Chinese and Western medicine to improve function in ankylosing spondylitis

  We will test whether combining Traditional Chinese and Western medicine improves how well adults with ankylosing spondylitis can function after six months.

  Recruiting China-Japan Friendship Hospital · Beijing, Beijing Municipality · NCT07556224

• Oxidative stress in autoimmune joint diseases

  Researchers will see if oxidative stress and antioxidant markers differ in adults with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

  Recruiting University of Thessaly · Larissa, Thessaly · NCT07536529

• Deep breathing added to core stability exercises for ankylosing spondylitis

  This program will test whether adding deep breathing to core stability exercises helps people with ankylosing spondylitis improve posture, breathing, and mobility.

  Recruiting Beni-Suef University · Banī Suwayf · NCT07262294

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.